Colin Kovacs

3.8k total citations · 1 hit paper
30 papers, 2.7k citations indexed

About

Colin Kovacs is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Colin Kovacs has authored 30 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Virology, 18 papers in Infectious Diseases and 12 papers in Immunology. Recurrent topics in Colin Kovacs's work include HIV Research and Treatment (25 papers), HIV/AIDS Research and Interventions (15 papers) and HIV/AIDS drug development and treatment (11 papers). Colin Kovacs is often cited by papers focused on HIV Research and Treatment (25 papers), HIV/AIDS Research and Interventions (15 papers) and HIV/AIDS drug development and treatment (11 papers). Colin Kovacs collaborates with scholars based in Canada, United States and Italy. Colin Kovacs's co-authors include Diana Finzi, Thomas C. Quinn, Joseph B. Margolick, Karen Chadwick, Stephen J. Gange, Janet D. Siliciano, Robert F. Siliciano, Anthony S. Fauci, Emanuela Marcenaro and Alessandro Moretta and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Colin Kovacs

30 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

2003 1.3k citations Janet D. Siliciano, Diana Finzi et al. Nature Medicine profile →

Peers

Countries citing papers authored by Colin Kovacs

Since Specialization

Citations

This map shows the geographic impact of Colin Kovacs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Kovacs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Kovacs more than expected).

Fields of papers citing papers by Colin Kovacs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Kovacs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Kovacs. The network helps show where Colin Kovacs may publish in the future.

Co-authorship network of co-authors of Colin Kovacs

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Kovacs. A scholar is included among the top collaborators of Colin Kovacs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Kovacs. Colin Kovacs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	When beauty is more than skin deep 2023 ·Canadian Family Physician ·Alice Tseng, Colin Kovacs, David Wong	1
2	Combination anti-HIV antibodies provide sustained virological suppression 2022 ·Nature ·Michael C. Sneller, Jana Blažková, J. Shawn Justement, Victoria Shi, (unknown), Kathleen Gittens, (unknown), Genevieve McCormack, (unknown), (unknown), Michael A. Proschan, Erika Benko, Colin Kovacs, Cihan Oguz, Michael S. Seaman, Marina Caskey, Michel C. Nussenzweig, Anthony S. Fauci, Susan Moir, Tae‐Wook Chun	100
3	Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy 2021 ·Nature Medicine ·Jana Blažková, Feng Gao, Manukumar Honnayakanahalli Marichannegowda, J. Shawn Justement, Victoria Shi, (unknown), (unknown), Erin Huiting, Kathleen Gittens, Mackenzie L. Cottrell, Erika Benko, Colin Kovacs, Justin Lack, Michael C. Sneller, Susan Moir, Anthony S. Fauci, Tae‐Wook Chun	31
4	Cardiovascular Events in an Inner-City HIV Clinic and Relationship to Abacavir Versus Tenofovir Disoproxil Fumarate-Containing Antiretroviral Regimens 2020 ·AIDS Research and Human Retroviruses ·(unknown), (unknown), (unknown), Graham Smith, Colin Kovacs, (unknown), Jason Brunetta, David Fletcher, (unknown), (unknown), Benny Chang, (unknown), (unknown), Mona Loutfy	1
5	Pharmacologic HIV-1 Nef blockade promotes CD8 T cell–mediated elimination of latently HIV-1–infected cells in vitro 2017 ·JCI Insight ·Shariq Mujib, (unknown), (unknown), (unknown), (unknown), Feng Yun Yue, Erika Benko, Colin Kovacs, Lori A. Emert‐Sedlak, Thomas E. Smithgall, Mario Ostrowski	27
6	Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals 2016 ·AIDS Care ·Paul A. Shuper, Narges Joharchi, Hyacinth Irving, David Fletcher, Colin Kovacs, Mona Loutfy, Sharon Walmsley, David Wong, Jürgen Rehm	20
7	Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials 2016 ·HIV Clinical Trials ·Connie J. Kim, Sharon Walmsley, Janet Raboud, Colin Kovacs, Bryan Coburn, (unknown), (unknown), Ron Rosenes, Rupert Kaul	32
8	Time to virologic failure for patients taking their first antiretroviral regimen and the subsequent resistance profiles 2014 ·Journal of the International AIDS Society ·(unknown), Anita C. Benoit, Colin Kovacs, Graham Smith, Nathan Taback, (unknown), Jason Brunetta, Benny Chang, (unknown), (unknown), David Fletcher, (unknown), Mona Loutfy	1
9	Latent TGF‐β1 is Compartmentalized Between Blood and Seminal Plasma of HIV‐Positive Men and Its Activation in Semen is Negatively Correlated with Viral Load and Immune Activation 2014 ·American Journal of Reproductive Immunology ·Jessica K. Kafka, B. Osborne, Prameet M. Sheth, Aisha Nazli, Sara Dizzell, Sanja Huibner, Colin Kovacs, Chris P. Verschoor, Dawn M. E. Bowdish, Rupert Kaul, Charu Kaushic	5
10	Herpes Simplex Virus Type 2 Coinfection Does Not Accelerate CD4 Count Decline in Untreated HIV Infection 2013 ·Clinical Infectious Diseases ·Darrell H. S. Tan, Janet Raboud, Rupert Kaul, Jason Brunetta, Charu Kaushic, Colin Kovacs, Edward Lee, (unknown), Anita Rachlis, Fiona Smaill, Marek Smieja, Sharon Walmsley	9
11	Epigenetic analysis of HIV-1 proviral genomes from infected individuals: Predominance of unmethylated CpG's 2013 ·Virology ·Stefanie Weber, Barbara Weiser, Kimdar Sherefa Kemal, Harold Burger, Christina M. Ramirez, Klaus Korn, Kathryn Anastos, Rupert Kaul, Colin Kovacs, Walter Doerfler	29
12	Short Communication: HIV Type 1 Accumulates in Influenza-Specific T Cells in Subjects Receiving Seasonal Vaccination in the Context of Effective Antiretroviral Therapy 2012 ·AIDS Research and Human Retroviruses ·R. Brad Jones, Colin Kovacs, Tae‐Wook Chun, Mario Ostrowski	8
13	The Recombinant Hepatitis B Surface Antigen Vaccine in Persons With HIV: Is Seroconversion Sufficient for Long-term Protection? 2012 ·The Journal of Infectious Diseases ·Jeff Powis, Janet Raboud, (unknown), Mona Loutfy, Colin Kovacs, Sharon Walmsley	13
14	Endometrial epithelial cell response to semen from HIV-infected men during different stages of infection is distinct and can drive HIV-1-long terminal repeat 2011 ·AIDS ·Jessica K. Kafka, Prameet M. Sheth, Aisha Nazli, B. Osborne, Colin Kovacs, Rupert Kaul, Charu Kaushic	28
15	Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals 2010 ·AIDS ·Jason Ho, Susan Moir, Wei Wang, Jacqueline G. Posada, Wenjuan Gu, (unknown), Robin Dewar, Colin Kovacs, Michael C. Sneller, Tae‐Wook Chun, Dean Follmann, Anthony S. Fauci	20
16	Persistent HIV RNA shedding in semen despite effective antiretroviral therapy 2009 ·AIDS ·Prameet M. Sheth, Colin Kovacs, Kimdar Sherefa Kemal, R. Brad Jones, Janet Raboud, Richard Pilon, Charles la Porte, Mario Ostrowski, Mona Loutfy, Harold Burger, Barbara Weiser, Rupert Kaul	108
17	Characterization of CD56^–/CD16⁺natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals 2005 ·Proceedings of the National Academy of Sciences ·Domenico Mavilio, Gabriella Lombardo, Janet Benjamin, Diana Kim, Dean Follman, Emanuela Marcenaro, Marie A. O’Shea, Audrey Kinter, Colin Kovacs, Alessandro Moretta, Anthony S. Fauci	414
18	Decreased Survival of B Cells of HIV-viremic Patients Mediated by Altered Expression of Receptors of the TNF Superfamily 2004 ·The Journal of Experimental Medicine ·Susan Moir, Angela Malaspina, Oxana K. Pickeral, Eileen T. Donoghue, Joshua Vasquez, Natalie J. Miller, (unknown), Marie A. Planta, (unknown), J. Shawn Justement, Shyamasundaran Kottilil, Mark Dybul, JoAnn M. Mican, Colin Kovacs, Tae‐Wook Chun, Charles E. Birse, Anthony S. Fauci	178
19	Clinical Impact of Double Protease Inhibitor Boosting with Lopinavir/Ritonavir and Amprenavir as Part of Salvage Antiretroviral Therapy 2003 ·HIV Clinical Trials ·Mona Loutfy, Janet Raboud, C. Thompson, Alice Tseng, (unknown), Colin Kovacs, Anita Rachlis, Elizabeth Phillips, (unknown), Kevin Gough, Sharon Walmsley	10
20	Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells breakdown → 2003 ·Nature Medicine ·Janet D. Siliciano, (unknown), Diana Finzi, Thomas C. Quinn, Karen Chadwick, Joseph B. Margolick, Colin Kovacs, Stephen J. Gange, Robert F. Siliciano	1283

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact